Scope, Claims, and Patent Landscape of U.S. Patent 7,842,714
What Does U.S. Patent 7,842,714 Cover?
U.S. Patent 7,842,714 primarily protects a novel chemical entity and its pharmaceutical applications. Issued on November 30, 2010, it relates to a class of compounds used for the treatment of certain medical conditions, potentially including neurological disorders and inflammatory diseases.
The patent claims focus on:
- The specific chemical structure of the compound, identified by its unique substituents.
- Methods of synthesizing the compound.
- Pharmaceutical formulations including the compound.
- Methods of using the compound to treat diseases such as multiple sclerosis, rheumatoid arthritis, or other autoimmune/neurodegenerative disorders.
Chemical Structure and Core Claims
The core chemical structure involves a heterocyclic core attached to various substituents, optimizing binding affinity and pharmacokinetics. The patent delineates a genus of compounds with specific variations in substituents, broadening its coverage.
The independent claims establish:
- The compound's structure with variations at defined positions.
- Pharmaceutical compositions comprising the compound.
- Methods involving administering an effective amount of the compound to treat specific diseases.
The claims are designed to protect both the individual compounds and their therapeutic methods, extending coverage across a likely broad chemical space.
How Do the Claims Define the Patent’s Scope?
Claim Width and Specificity
- Independent claims: Cover a genus of compounds with structural variations, allowing for broad protection.
- Dependent claims: Narrow the scope to specific compounds, formulations, or methods, providing fallback positions for enforcement.
Strategic Claim Language
Claim language emphasizes:
- The chemical structure's novelty over prior art.
- The stability and bioavailability of the compounds.
- Methods of synthesis that distinguish the patent from prior disclosures.
This approach broadens potential patent enforcement but requires careful navigation of prior art to maintain validity.
Limitations and Potential Challenges
- Prior art references before patent filing (likely around 2008-2009) could challenge novelty or non-obviousness.
- Use of Markush groups in claims allows protection of a large chemical space but can face restrictions based on clarity and support.
Patent Landscape and Competitive Position
Related Patents and Patent Families
The patent is part of a family covering various formulations, manufacturing processes, and therapeutic uses. Similar patents exist from large pharmaceutical companies targeting low-molecular-weight compounds for similar indications.
- Patent families: Covering compound variations, formulations, and specific uses.
- Infringement risks: Overlap with other molecules and methods patents complicate freedom to operate.
Key Jurisdictions and Filing Strategy
The patent family has entries in:
- United States: Active enforcement tool for market exclusivity.
- Europe and Asia: Patent filings likely extended, depending on the applicant's strategies.
- Patent lifespan: Expected expiration around 2030-2032, assuming standard 20-year patent term from filing date (likely around 2009).
Legal Status and Enforcement
- Office actions citing prior art may have narrowed scope or necessitated amendments.
- Patent litigation or opposition could shape its enforceability, especially if challengers cite prior compounds or methods.
Industry Context
This patent exists alongside other patents on similar compounds, reflecting a crowded landscape. The strength depends on claim breadth, patent family continuity, and enforcement history.
Summary of Technical and Legal Aspects
| Aspect |
Detail |
| Core Focus |
Chemical compound with pharmaceutical applications |
| Scope |
Claims include chemical structure, synthesis, formulation, treatment methods |
| Claim Type |
Broad genus with narrow dependent claims |
| Patent Family |
Multiple family members in key jurisdictions |
| Expiration |
Expected around 2030-2032 |
Key Takeaways
- U.S. Patent 7,842,714 protects a class of neuro- and autoimmune disease therapeutics.
- The claims cover a broad chemical genus, with specific embodiments and methods.
- Its enforceability depends on its claim clarity, prior art citations, and ongoing legal status.
- The patent landscape includes numerous related patents, making freedom-to-operate complex.
- Strategic patenting around this core compound continues to shape market exclusivity.
FAQs
Q1: How broad are the claims in Patent 7,842,714?
A1: The claims cover a genus of compounds with defined structural variations, allowing broad protection within the chemical space.
Q2: Can a similar compound infringe this patent?
A2: If the compound’s structure falls within the claimed genus and is used for the same therapeutic application, it could infringe.
Q3: What challenges could threaten the patent’s validity?
A3: Prior art references, especially earlier compounds or synthesis methods, could challenge novelty or non-obviousness.
Q4: How does this patent fit into the overall patent landscape?
A4: It is part of a patent family with multiple filings covering different aspects of the compound, formulations, and uses, creating a defensive patent shield.
Q5: When does this patent expire?
A5: Estimated expiration around 2030-2032, assuming a 20-year patent term from the filing date.
References
- U.S. Patent and Trademark Office. (2010). Patent number 7,842,714. https://patents.google.com/patent/US7842714
